C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 9/127 (2006.01) A61K 31/70 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C12N 15/62 (2006.01) C12N 15/88 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2235810
The use of liposomal formulations, particularly formulations of positively charged and neutral lipids facilitates cellular uptake of SDI molecules. The transcription and/or expression of SDI-1-encoding nucleic acid molecules is facilitated by constructs that contain intervening untranslated regions.
L'utilisation de formulations liposomiques, en particulier, des formulations de lipides neutres et positivement chargés facilite le captage cellulaire de molécules d'inhibiteurs produits dans des cellules sénescentes (SDI). La transcription et/ou l'expression de molécules d'acide nucléique codant SDI-1 est facilitée par des produits de recombinaison contenant des régions intervenantes non traduites.
Drutz David J.
Smith James R.
Wilson Deborah R.
Zumstein Louis A.
Baylor College Of Medicine
Fetherstonhaugh & Co.
Sennes Drug Innovations Inc.
LandOfFree
Senescent cell-derived inhibitors of dna synthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Senescent cell-derived inhibitors of dna synthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Senescent cell-derived inhibitors of dna synthesis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1499296